Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment

Neuropharmacology

Volumn 96, Issue PB, 2015, Pages 255-262

  Lombardo, Sylvia ^a,b   Maskos, Uwe ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

Author keywords

Alzheimer's disease; A peptide; Cholinergic system; Nicotine; Nicotinic receptor

Indexed keywords

1,4 DIAZABICYCLO[3.2.2]NONANE 4 CARBOXYLIC ACID 4 BROMOPHENYL ESTER; 2 [2 (4 BROMOPHENYL) 2 OXOETHYL] 1 METHYLPYRIDINIUM IODIDE; 4 O H GTS 21; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BUNGAROTOXIN RECEPTOR; COTININE; METHYLLYCACONITINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; NOOTROPIC AGENT; PREGNENOLONE SULFATE; PTI 125; SIMVASTATIN; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; MUSCARINIC RECEPTOR; NICOTINE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; DRUG EFFICACY; HUMAN; LONG TERM POTENTIATION; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NERVE CELL; PATHOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MICE, TRANSGENIC; NEURONS; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC;

EID: 84932198001     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.11.018     Document Type: Review

References (109)

1. E.X. Albuquerque, E.F.R. Pereira, M. Alkondon, and S.W. Rogers Mammalian nicotinic acetylcholine receptors: from structure to function Physiol. Rev. 89 2009 73 120
2. K. Arora, N. Alfulaij, J.K. Higa, J. Panee, and R.A. Nichols Impact of sustained exposure to β-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptors J. Biol. Chem. 288 2013 11175 11190
3. D.S. Auld, T.J. Kornecook, S. Bastianetto, and R. Quirion Alzheimer's disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies Prog. Neurobiol. 68 2002 209 245
4. R.T. Bartus, R.L. Dean, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
5. D.K. Berg, and W.G. Conroy Nicotinic α7 receptors: synaptic options and downstream signaling in neurons J. Neurobiol. 53 2002 512 523
6. V. Bigl, N.J. Woolf, and L.L. Butcher Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis Brain Res. Bull. 8 1982 727 749
7. B. Biton, O.E. Bergis, F. Galli, A. Nedelec, A.W. Lochead, S. Jegham, D. Godet, C. Lanneau, R. Santamaria, and F. Chesney SSR180711, a novel selective α7 nicotinic receptor partial agonist: (1) binding and functional profile Neuropsychopharmacology 32 2006 1 16
8. D.M. Bowen, C.B. Smith, P. White, and A.N. Davison Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies Brain J. Neurol. 99 1976 459 496
9. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. (Berl.) 82 1991 239 259
10. J.-P. Changeux, and S.J. Edelstein Allosteric receptors after 30 years Neuron 21 1998 959 980
11. A. Contestabile The history of the cholinergic hypothesis Behav. Brain Res. 221 2011 334 340
12. J.T. Coyle, D.L. Price, and M.R. DeLong Alzheimer's disease: a disorder of cortical cholinergic innervation Science 219 1983 1184 1190
13. J.A. Dani, and D. Bertrand Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system Annu. Rev. Pharmacol. Toxicol. 47 2007 699 729
14. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 1976 1403
15. K.T. Dineley, M. Westerman, D. Bui, K. Bell, K.H. Ashe, and J.D. Sweatt β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease J. Neurosci. 21 2001 4125 4133
16. K.T. Dineley, K.A. Bell, D. Bui, and J.D. Sweatt β-amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes J. Biol. Chem. 277 2002 25056 25061
17. J.J. Dougherty, J. Wu, and R.A. Nichols β-amyloid regulation of presynaptic nicotinic receptors in rat Hippocampus and neocortex J. Neurosci. 23 2003 6740 6747
18. G. Dziewczapolski, C.M. Glogowski, E. Masliah, and S.F. Heinemann Deletion of the α7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease J. Neurosci. 29 2009 8805 8815
19. V. Echeverria, and R. Zeitlin Cotinine: a potential new therapeutic agent against Alzheimer's disease CNS Neurosci. Ther. 18 2012 517 523
20. V. Echeverria, R. Zeitlin, S. Burgess, S. Patel, A. Barman, G. Thakur, M. Mamcarz, L. Wang, D.B. Sattelle, and D.A. Kirschner Cotinine reduces amyloid-β aggregation and improves memory in Alzheimer's disease mice J. Alzheimers Dis. 24 2011 817 835
21. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Borthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson, and F. Gillespie Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein Nature 373 1995 523 527
22. J. Gao, B.-L. Adam, and A.V. Terry Jr. Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease Bioorg. Med. Chem. Lett. 24 2014 1472 1478
23. M.M. Ghoneim, and S.P. Mewaldt Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine Psychopharmacol. (Berl.) 52 1977 1 6
24. R. Giniatullin, A. Nistri, and J.L. Yakel Desensitization of nicotinic ACh receptors: shaping cholinergic signaling Trends Neurosci. 28 2005 371 378
25. C. Gotti, and F. Clementi Neuronal nicotinic receptors: from structure to pathology Prog. Neurobiol. 74 2004 363 396
26. C. Gotti, M. Moretti, I. Bohr, I. Ziabreva, S. Vailati, R. Longhi, L. Riganti, A. Gaimarri, I.G. McKeith, and R.H. Perry Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation Neurobiol. Dis. 23 2006 481 489
27. C. Gotti, M. Zoli, and F. Clementi Brain nicotinic acetylcholine receptors: native subtypes and their relevance Trends Pharmacol. Sci. 27 2006 482 491
28. C. Gotti, M. Moretti, A. Gaimarri, A. Zanardi, F. Clementi, and M. Zoli Heterogeneity and complexity of native brain nicotinic receptors Biochem. Pharmacol. 74 2007 1102 1111
29. C. Gotti, F. Clementi, A. Fornari, A. Gaimarri, S. Guiducci, I. Manfredi, M. Moretti, P. Pedrazzi, L. Pucci, and M. Zoli Structural and functional diversity of native brain neuronal nicotinic receptors Biochem. Pharmacol. 78 2009 703 711
30. K. Guillem, B. Bloem, R.B. Poorthuis, M. Loos, A.B. Smit, U. Maskos, S. Spijker, and H.D. Mansvelder Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention Science 333 2011 888 891
31. D.K. Hatsukami, M. Grillo, P.R. Pentel, C. Oncken, and R. Bliss Safety of cotinine in humans: physiologic, subjective, and cognitive effects Pharmacol. Biochem. Behav. 57 1997 643 650
32. E. Hellström-Lindahl, J. Court, J. Keverne, M. Svedberg, M. Lee, A. Marutle, A. Thomas, E. Perry, I. Bednar, and A. Nordberg Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice Eur. J. Neurosci. 19 2004 2703 2710
33. C.M. Hernandez, R. Kayed, H. Zheng, J.D. Sweatt, and K.T. Dineley Loss of α7 nicotinic receptors enhances β-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease J. Neurosci. 30 2010 2442 2453
34. A.Y. Hsia, E. Masliah, L. McConlogue, G.-Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R.C. Malenka, R.A. Nicoll, and L. Mucke Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc. Natl. Acad. Sci. 96 1999 3228 3233
35. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
36. N.C. Inestrosa, J.A. Godoy, J.Y. Vargas, M.S. Arrazola, J.A. Rios, F.J. Carvajal, F.G. Serrano, and G.G. Farias Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation Neuro Molecular Med. 15 2013 549 569
37. S.S. Khiroug, P.C. Harkness, P.W. Lamb, S.N. Sudweeks, L. Khiroug, N.S. Millar, and J.L. Yakel Rat nicotinic ACh receptor 7 and 2 subunits co-assemble to form functional heteromeric nicotinic receptor channels J. Physiol. 540 2002 425 434
38. T. Kihara, S. Shimohama, H. Sawada, K. Honda, T. Nakamizo, H. Shibasaki, T. Kume, and A. Akaike α7 nicotinic receptor transduces signals to phosphatidylinositol 3-Kinase to block A β-Amyloid-induced neurotoxicity J. Biol. Chem. 276 2001 13541 13546
39. H.-J. Kim, W.-J. Moon, and S.-H. Han Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia J. Alzheimers Dis. 35 2013 129 136
40. P.W. Lamb, M.A. Melton, and J.L. Yakel Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by beta-amyloid1-42 peptide J. Mol. Neurosci. 27 2005 13 21
41. N.L. Le Novère, and J.-P. Changeux Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells J. Mol. Evol. 40 1995 155 172
42. A.M. Lilja, O. Porras, E. Storelli, A. Nordberg, and A. Marutle Functional interactions of fibrillar and oligomeric amyloid-β with Alpha7 nicotinic receptors in Alzheimer's disease J. Alzheimers Dis. 23 2011 335 347
43. Q. Liu, H. Kawai, and D.K. Berg β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons Proc. Natl. Acad. Sci. 98 2001 4734 4739
44. Q. Liu, Y. Huang, F. Xue, A. Simard, J. DeChon, G. Li, J. Zhang, L. Lucero, M. Wang, and M. Sierks A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides J. Neurosci. 29 2009 918 929
45. Q. Liu, Y. Huang, J. Shen, S. Steffensen, and J. Wu Functional alpha7beta2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid ß peptides BMC Neurosci. 13 2012 155 166
46. A.F. Lozada, X. Wang, N.V. Gounko, K.A. Massey, J. Duan, Z. Liu, and D.K. Berg Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors J. Neurosci. 32 2012 7651 7661
47. S.E. Martin, N.E.C. de Fiebre, and C.M. de Fiebre The α7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against β-amyloid1-42 toxicity in primary neuron-enriched cultures Brain Res. 1022 2004 254 256
48. E. Masliah, M. Mallory, M. Alford, R. DeTeresa, L.A. Hansen, D.W.J. McKeel, and J.C. Morris Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease Neurology 56 2001 127 129
49. M. Messi, M. Renganathan, E. Grigorenko, and O. Delbono Activation of α7 nicotinic acetylcholine receptor promotes survival of spinal cord motoneurons FEBS Lett. 411 1997 32 38
50. M.M. Mesulam, E.J. Mufson, A.I. Levey, and B.H. Wainer Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey J. Comp. Neurol. 214 1983 170 197
51. M. Moretti, M. Zoli, A.A. George, R.J. Lukas, F. Pistillo, U. Maskos, P. Whiteaker, and C. Gotti The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization Mol. Pharmacol. 86 2014 306 317
52. B.J. Morley, and H.K. Happe Cholinergic receptors: dual roles in transduction and plasticity Hear. Res. 147 2000 104 112
53. L. Mucke, E. Masliah, G.-Q. Yu, M. Mallory, E.M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J. Neurosci. 20 2000 4050 4058
54. J.L. Muir, K.J. Page, D.J. Sirinathsinghji, T.W. Robbins, and B.J. Everitt Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention Behav. Brain Res. 57 1993 123 131
55. T.A. Murray, D. Bertrand, R.L. Papke, A.A. George, R. Pantoja, R. Srinivasan, Q. Liu, J. Wu, P. Whiteaker, and H.A. Lester α7β2 nicotinic acetylcholine receptors assemble, function, and are activated primarily via their α7-α7 interfaces Mol. Pharmacol. 81 2012 175 188
56. A. Nordberg, E. Hellström-Lindahl, M. Lee, M. Johnson, M. Mousavi, R. Hall, E. Perry, I. Bednar, and J. Court Chronic nicotine treatment reduces β-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) J. Neurochem. 81 2002 655 658
57. S. Oddo, A. Caccamo, K.N. Green, K. Liang, L. Tran, Y. Chen, F.M. Leslie, and F.M. LaFerla Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 102 2005 3046 3051
58. G. Olivero, M. Grilli, J. Chen, S. Preda, E. Mura, S. Govoni, and M. Marchi Effects of soluble β-amyloid on the release of neurotransmitters from rat brain synaptosomes Front. Aging Neurosci. 6 2014 166
59. A. Orr-Urtreger, F.M. Göldner, M. Saeki, I. Lorenzo, L. Goldberg, M.D. Biasi, J.A. Dani, J.W. Patrick, and A.L. Beaudet Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-Bungarotoxin binding sites and hippocampal fast nicotinic currents J. Neurosci. 17 1997 9165 9171
60. A. Pandya, and J.L. Yakel Allosteric modulator desformylflustrabromine relieves the inhibition of α2ß2 and α4ß2 nicotinic acetylcholine receptors by ß-amyloid1-42 peptide J. Mol. Neurosci. 45 2011 42 47
61. H.R. Parri, C.M. Hernandez, and K.T. Dineley Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease Biochem. Pharmacol. 82 2011 931 942
62. D. Paterson, and A. Nordberg Neuronal nicotinic receptors in the human brain Prog. Neurobiol. 61 2000 75 111
63. E.K. Perry, B.E. Tomlinson, G. Blessed, K. Bergmann, P.H. Gibson, and R.H. Perry Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia Br. Med. J. 2 1978 1457 1459
64. E.K. Perry, G. Blessed, B.E. Tomlinson, R.H. Perry, T.J. Crow, A.J. Cross, G.J. Dockray, R. Dimaline, and A. Arregui Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes Neurobiol. Aging 2 1981 251 256
65. E.K. Perry, M. Curtis, D.J. Dick, J.M. Candy, J.R. Atack, C.A. Bloxham, G. Blessed, A. Fairbairn, B.E. Tomlinson, and R.H. Perry Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease J. Neurol. Neurosurg. Psychiatry 48 1985 413 421
66. E.K. Perry, R.H. Perry, C.J. Smith, D.J. Dick, J.M. Candy, J.A. Edwardson, A. Fairbairn, and G. Blessed Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases J. Neurol. Neurosurg. Psychiatry 50 1987 806 809
67. G. Perry, S. Lipphardt, P. Mulvihill, M. Kancherla, M. Mijares, P. Gambetti, S. Sharma, L. Maggiora, J. Cornette, and T. Lobl Amyloid precursor protein in senile plaques of Alzheimer disease Lancet 2 1988 746
68. R.C. Petersen Scopolamine induced learning failures in man Psychopharmacol. (Berl.) 52 1977 283 289
69. D.L. Pettit, Z. Shao, and J.L. Yakel β-Amyloid1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice J. Neurosci. 21 2001 RC120-RC120
70. L.D. Plant, J.P. Boyle, I.F. Smith, C. Peers, and H.A. Pearson The production of amyloid β peptide is a Critical Requirement for the Viability of Central neurons J. Neurosci. 23 2003 5531 5535
71. D. Puzzo, L. Privitera, E. Leznik, M. Fà, A. Staniszewski, A. Palmeri, and O. Arancio Picomolar amyloid-β positively modulates synaptic plasticity and memory in Hippocampus J. Neurosci. 28 2008 14537 14545
72. L. Pym, M. Kemp, V. Raymond-Delpech, S. Buckingham, C.a.R. Boyd, and D. Sattelle Subtype-specific actions of β-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (α7, α4β2, α3β4) expressed in Xenopus laevis oocytes Br. J. Pharmacol. 146 2005 964 971
73. M.W. Quick, and R.A.J. Lester Desensitization of neuronal nicotinic receptors J. Neurobiol. 53 2002 457 478
74. K. Ren, M.A. King, J. Liu, J. Siemann, M. Altman, C. Meyers, J.A. Hughes, and E.M. Meyer The α7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice Neuroscience 148 2007 230 237
75. M. Sarter, and J.P. Bruno Cognitive functions of cortical acetylcholine: toward a unifying hypothesis Brain Res. Rev. 23 1997 28 46
76. M. Sarter, and G. Paolone Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches Behav. Neurosci. 125 2011 825 835
77. D.J. Selkoe The molecular pathology of Alzheimer's disease Neuron 6 1991 487 498
78. D.J. Selkoe Alzheimer's disease Cold Spring Harb. Perspect. Biol. 3 2011
79. S.B. Shim, S.H. Lee, K.R. Chae, C.K. Kim, D.Y. Hwang, B.G. Kim, S.W. Jee, S.H. Lee, J.S. Sin, and C.J. Bae Nicotine leads to improvements in behavioral impairment and an increase in the nicotine acetylcholine receptor in transgenic mice Neurochem. Res. 33 2008 1783 1788
80. S. Shimohama, T. Taniguchi, M. Fujiwara, and M. Kameyama Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia J. Neurochem. 46 1986 288 293
81. M. Simons, F. Schwärzler, D. Lütjohann, K. Von Bergmann, K. Beyreuther, J. Dichgans, H. Wormstall, T. Hartmann, and J.B. Schulz Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: a 26-week randomized, placebo-controlled, double-blind trial Ann. Neurol. 52 2002 346 350
82. C.C. Smith, T.T. Gibbs, and D.H. Farb Pregnenolone sulfate as a modulator of synaptic plasticity Psychopharmacol. (Berl.) 231 2014 3537 3556
83. A. Søderman, M.S. Thomsen, H.H. Hansen, E.Ø. Nielsen, M.S. Jensen, M.J. West, and J.D. Mikkelsen The nicotinic α7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-β1-42 Brain Res. 1227 2008 240 247
84. A. Söderman, J.D. Mikkelsen, M.J. West, D.Z. Christensen, and M.S. Jensen Activation of nicotinic α7 acetylcholine receptor enhances long term potentation in wild type mice but not in APPswe/PS1ΔE9 mice Neurosci. Lett. 487 2011 325 329
85. D.L. Sparks, M. Sabbagh, D. Connor, H. Soares, J. Lopez, G. Stankovic, S. Johnson-Traver, C. Ziolkowski, and P. Browne Statin therapy in Alzheimer's disease Acta Neurol. Scand. 114 2006 78 86
86. T.L. Spires-Jones, and B.T. Hyman The intersection of amyloid beta and tau at synapses in Alzheimer's disease Neuron 82 2014 756 771
87. T.P. Stossel, J. Condeelis, L. Cooley, J.H. Hartwig, A. Noegel, M. Schleicher, and S.S. Shapiro Filamins as integrators of cell mechanics and signalling Nat. Rev. Mol. Cell. Biol. 2 2001 138 145
88. S.N. Sudweeks, and J.L. Yakel Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons J. Physiol. 527 2000 515 528
89. H. Tozaki, A. Matsumoto, T. Kanno, K. Nagai, T. Nagata, S. Yamamoto, and T. Nishizaki The inhibitory and facilitatory actions of amyloid-β peptides on nicotinic ACh receptors and AMPA receptors Biochem. Biophys. Res. Commun. 294 2002 42 45
90. D.M. Walsh, and D.J. Selkoe Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration Protein Pept. Lett. 11 2004 213 228
91. H.-Y. Wang, D.H.S. Lee, M.R. D'Andrea, P.A. Peterson, R.P. Shank, and A.B. Reitz β-Amyloid1-42 binds to α7 nicotinic acetylcholine receptor with high affinity implications for Alzheimer's disease pathology J. Biol. Chem. 275 2000 5626 5632
92. H.-Y. Wang, D.H.S. Lee, C.B. Davis, and R.P. Shank Amyloid peptide Aβ1-42 binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors J. Neurochem. 75 2000 1155 1161
93. H.-Y. Wang, A. Stucky, J. Liu, C. Shen, C. Trocme-Thibierge, and P. Morain Dissociating β-amyloid from α7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes α7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain J. Neurosci. 29 2009 10961 10973
94. H.-Y. Wang, K. Bakshi, C. Shen, M. Frankfurt, C. Trocmé-Thibierge, and P. Morain S 24795 Limits β-amyloid-α7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies Biol. Psychiatry 67 2010 522 530
95. H.-Y. Wang, K. Bakshi, M. Frankfurt, A. Stucky, M. Goberdhan, S.M. Shah, and L.H. Burns Reducing amyloid-related Alzheimer's disease pathogenesis by a small molecule targeting filamin A J. Neurosci. 32 2012 9773 9784
96. G.L. Wenk The nucleus basalis magnocellularis cholinergic system: one hundred years of progress Neurobiol. Learn. Mem. 67 1997 85 95
97. P.J. Whitehouse, D.L. Price, A.W. Clark, J.T. Coyle, and M.R. DeLong Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis Ann. Neurol. 10 1981 122 126
98. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle, and M.R. Delon Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain Science 215 1982 1237 1239
99. P.J. Whitehouse, A.M. Martino, P.G. Antuono, P.R. Lowenstein, J.T. Coyle, D.L. Price, and K.J. Kellar Nicotinic acetylcholine binding sites in Alzheimer's disease Brain Res. 371 1986 146 151
100. S. Wonnacott, J. Barik, J. Dickinson, and I.W. Jones Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters J. Mol. Neurosci. 30 2006 137 140
101. N.J. Woolf A structural basis for memory storage in mammals Prog. Neurobiol. 55 1998 59 77
102. J. Wu, Y.-P. Kuo, A.A. George, L. Xu, J. Hu, and R.J. Lukas β-Amyloid directly inhibits human α4β2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells J. Biol. Chem. 279 2004 37842 37851
103. R. Yang, L. Chen, H. Wang, B. Xu, H. Tomimoto, and L. Chen Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection Neuropharmacology 63 2012 1042 1050
104. J.W. Young, K. Finlayson, C. Spratt, H.M. Marston, N. Crawford, J.S. Kelly, and J. Sharkey Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor Neuropsychopharmacology 29 2004 891 900
105. J.W. Young, N. Crawford, J.S. Kelly, L.E. Kerr, H.M. Marston, C. Spratt, K. Finlayson, and J. Sharkey Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice Eur. Neuropsychopharmacol. 17 2007 145 155
106. A. Zanardi, R. Ferrari, G. Leo, U. Maskos, J.-P. Changeux, and M. Zoli Loss of high-affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment FASEB J. 21 2007 4028 4037
107. W.-H. Zhi, Y.-Y. Zeng, Z.-H. Lu, W.-J. Qu, W.-X. Chen, L. Chen, and L. Chen Simvastatin exerts antiamnesic effect in Aβ25-35-injected mice CNS Neurosci. Ther. 20 2014 218 226
108. M. Zoli, C. Léna, M.R. Picciotto, and J.P. Changeux Identification of four classes of brain nicotinic receptors using beta2 mutant mice J. Neurosci. 18 1998 4461 4472
109. M. Zoli, M.R. Picciotto, R. Ferrari, D. Cocchi, and J.P. Changeux Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors EMBO J. 18 1999 1235 1244